Ayala Pharmaceuticals Inc. – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 12/31/23 FY 2023 – amended

ended 12/31/23 FY 2023

Late annual filing notification for FY 2024

ended 09/30/23 Q3

Late quarterly filing notification for Q3 2023

Prospectuses and Registrations Filter

Securities registration termination

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Ownership Filter

OS Therapies Incorporated

Israel Biotech Fund I, L.P., Israel Biotech Fund II, L.P., I.B.F. Management Ltd., Israel Biotech Fund GP Partners, L.P., Israel Biotech Fund GP Partners II, L.P.

Redmile Group, LLC

Israel Biotech Fund I, L.P., Israel Biotech Fund II, L.P., I.B.F. Management Ltd., Israel Biotech Fund GP Partners, L.P., Israel Biotech Fund GP Partners II, L.P.

Israel Biotech Fund I, L.P.

News Filter

Financial Statements or Exhibits

Change in Directors, Officers or Compensation

Announces Completion of Sale of AL102 to Immunome

Material Definitive Agreement, New Financial Obligation or Off-Balance Sheet Arrangement, Financial Statements or Exhibits

February 20, 2024 Andres A. Gutierrez, MD, PhD

Proxies Filter

Info related to merger

Preliminary info related to merger

Definitive proxy

Definitive proxy

Preliminary proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC